Long-term prostacyclin infusion to reduce pulmonary hypertension in a pediatric cardiac transplant candidate prior to transplantation

Bernard Kao, David T. Balzer, Charles B. Huddleston, Charles E. Canter

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Pulmonary hypertension represents a significant risk factor for peri-operative death in patients undergoing cardiac transplantation. Heart-lung transplantation is generally the only procedure available for patients whose pulmonary hypertension can not be reversed by conventional pharmacologic means. We present a pediatric patient with end-stage cardiac disease and refractory pulmonary hypertension who was treated with long-term intravenous prostacyclin. This resulted in a significant enough improvement in her hemodynamics to allow for successful cardiac transplantation alone.

Original languageEnglish
Pages (from-to)785-788
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume20
Issue number7
DOIs
StatePublished - Jul 24 2001

Fingerprint Dive into the research topics of 'Long-term prostacyclin infusion to reduce pulmonary hypertension in a pediatric cardiac transplant candidate prior to transplantation'. Together they form a unique fingerprint.

  • Cite this